select a format

Single User License
USD 250 INR 16023
Site License
USD 500 INR 32045
Corporate User License
USD 750 INR 48068

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"


Ocata Therapeutics Inc-Pharmaceuticals & Healthcare-Deals and Alliances Profile

Ocata Therapeutics Inc-Pharmaceuticals & Healthcare-Deals and Alliances Profile


  • Products Id :- GDPH4262D
  • |
  • Pages: 32
  • |
  • November 2016
  • |
  • |
  Request for Sample Report

Executive Summary

Ocata Therapeutics Inc (Ocata) formerly known as Advanced Cell Technology, Inc. is a clinical stage biotechnology company that specializes in regenerative medicine. The company develops and commercializes for various ophthalmological disorders including Stargardt's macular degeneration, dry age-related macular degeneration, and myopic macular degeneration. It key development programs include RPE Cell Therapy; Photoreceptor Progenitor Cell Therapy; Ganglion Progenitor Cell Therapy and Corneal Endothelial Cells. The company also has projects in preclinical development for various indications including autoimmune, inflammatory and wound healing-related disorders. It operates a laboratory and manufacturing facility in Marlborough, in the US. Ocata is headquartered in Marlborough, Massachusetts, the US.

Ocata Therapeutics Inc-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
ankur [@] kenresearch.com
+91-9015378249
www.kenresearch.com

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Ocata Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5

Ocata Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6

Ocata Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7

Ocata Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8

Ocata Therapeutics Inc, Medical Devices Deals, 2010 to YTD 2016 9

Ocata Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10

Ocata Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 11

Venture Financing 11

Ocata Therapeutics Secures USD6 Million from Silicon Valley Bank 11

Partnerships 12

Advanced Cell Enters Into Co-Marketing Agreement With Roslin Cells 12

Licensing Agreements 14

Ocata Therapeutics Enters into Licensing Agreement with Allele Biotech 14

International Stem Cell Amends Licensing Agreement With Advanced Cell Technology 15

SCRMI Enters Into Licensing Agreement With Advanced Cell And CHA Bio 16

Equity Offering 18

Ocata Therapeutics Prices Public Offering of Shares and Warrants for USD30 Million 18

Advanced Cell to Raise USD30 Million in Private Placement of Shares 20

Advanced Cell Technology Files Registration Statement For Public Offering Of Securities For US$35 Million 21

Advanced Cell Technology Completes First Tranche Of Private Placement Of Shares For US$1 Million 22

Advanced Cell Technology Completes Private Placement Of US$4 Million 23

Advanced Cell Technology Completes First Tranche Private Placement Of US$1.5 Million 25

Acquisition 27

Astellas Pharma Acquires Ocata Therapeutics for up to USD384 Million in Tender Offer 27

Ocata Therapeutics Inc-Key Competitors 29

Key Employees 30

Locations And Subsidiaries 31

Head Office 31

Other Locations & Subsidiaries 31

Appendix 32

Methodology 32

About GlobalData 32

Contact Us 32

Disclaimer 32

List of Figures

Ocata Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1

Ocata Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1

Ocata Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1

Ocata Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1

Ocata Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5

Ocata Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6

Ocata Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7

Ocata Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8

Ocata Therapeutics Inc, Medical Devices Deals, 2010 to YTD 2016 9

List of Tables

Ocata Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts, 2014 1

Ocata Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5

Ocata Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6

Ocata Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7

Ocata Therapeutics Inc, Deals By Therapy Area, 2010 to YTD 2016 8

Ocata Therapeutics Inc, Medical Devices Deals, 2010 to YTD 2016 9

Ocata Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10

Ocata Therapeutics Secures USD6 Million from Silicon Valley Bank 11

Advanced Cell Enters Into Co-Marketing Agreement With Roslin Cells 12

Ocata Therapeutics Enters into Licensing Agreement with Allele Biotech 14

International Stem Cell Amends Licensing Agreement With Advanced Cell Technology 15

SCRMI Enters Into Licensing Agreement With Advanced Cell And CHA Bio 16

Ocata Therapeutics Prices Public Offering of Shares and Warrants for USD30 Million 18

Advanced Cell to Raise USD30 Million in Private Placement of Shares 20

Advanced Cell Technology Files Registration Statement For Public Offering Of Securities For US$35 Million 21

Advanced Cell Technology Completes First Tranche Of Private Placement Of Shares For US$1 Million 22

Advanced Cell Technology Completes Private Placement Of US$4 Million 23

Advanced Cell Technology Completes First Tranche Private Placement Of US$1.5 Million 25

Astellas Pharma Acquires Ocata Therapeutics for up to USD384 Million in Tender Offer 27

Ocata Therapeutics Inc, Key Competitors 29

Ocata Therapeutics Inc, Key Employees 30

Ocata Therapeutics Inc, Other Locations 31

Ocata Therapeutics Inc, Subsidiaries 31

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Ocata Therapeutics Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.


Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com